Meet a protein aficionado working on a new way to treat COVID-19. As an expert on proteins, biochemist Barry Honig, PhD, has explored a huge variety of topics during his career: from color vision to cancer. He’s a theorist, a scientist interested in understanding general principles of how proteins interact and how those principles carry over from one problem to the next.   In this episode, explore how Dr. Honig is applying lessons learned from studying brain cells to the treatment of coronavirus. He and his colleagues recently received a grant to build better antibodies that block viruses from penetrating human cells. Inspired by previous works on AIDS, such antibodies could provide a new way to combat COVID-19. 

Lab in the Time of Coronavirus

Columbia University's Zuckerman Institute

Building a Better Antibody

FEB 22, 20218 MIN
Lab in the Time of Coronavirus

Building a Better Antibody

FEB 22, 20218 MIN

Description

Meet a protein aficionado working on a new way to treat COVID-19. As an expert on proteins, biochemist Barry Honig, PhD, has explored a huge variety of topics during his career: from color vision to cancer. He’s a theorist, a scientist interested in understanding general principles of how proteins interact and how those principles carry over from one problem to the next.

 

In this episode, explore how Dr. Honig is applying lessons learned from studying brain cells to the treatment of coronavirus. He and his colleagues recently received a grant to build better antibodies that block viruses from penetrating human cells. Inspired by previous works on AIDS, such antibodies could provide a new way to combat COVID-19.